130 related articles for article (PubMed ID: 34657081)
21. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
22. Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases.
Chen WW; Wang F; Zhang DS; Luo HY; Wang ZQ; Wang FH; Qiu MZ; Ren C; Wei XL; Wu WJ; Li YH; Xu RH
BMC Cancer; 2014 Mar; 14():222. PubMed ID: 24666414
[TBL] [Abstract][Full Text] [Related]
23. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum.
Takahashi H; Ishii H; Nishida N; Takemasa I; Mizushima T; Ikeda M; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2011 Apr; 18(4):1166-74. PubMed ID: 21125339
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
25. Prox1 regulates the notch1-mediated inhibition of neurogenesis.
Kaltezioti V; Kouroupi G; Oikonomaki M; Mantouvalou E; Stergiopoulos A; Charonis A; Rohrer H; Matsas R; Politis PK
PLoS Biol; 2010 Dec; 8(12):e1000565. PubMed ID: 21203589
[TBL] [Abstract][Full Text] [Related]
26. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.
Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281
[TBL] [Abstract][Full Text] [Related]
27. Unidirectional and stage-dependent roles of Notch1 in Wnt-responsive Lgr5
Jiang H; Zeng S; Ni W; Chen Y; Li W
Front Med; 2019 Dec; 13(6):705-712. PubMed ID: 31598881
[TBL] [Abstract][Full Text] [Related]
28. Prox 1, VEGF-C and VEGFR3 expression during cervical neoplasia progression as evidence of an early lymphangiogenic switch.
Cimpean AM; Mazuru V; Saptefrati L; Ceausu R; Raica M
Histol Histopathol; 2012 Dec; 27(12):1543-50. PubMed ID: 23059885
[TBL] [Abstract][Full Text] [Related]
29. Expression and functional regulation of stemness gene Lgr5 in esophageal squamous cell carcinoma.
Lv Z; Yu JJ; Zhang WJ; Xiong L; Wang F; Li LF; Zhou XL; Gao XY; Ding XF; Han L; Cai YF; Ma W; Wang LX
Oncotarget; 2017 Apr; 8(16):26492-26504. PubMed ID: 28404917
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Impact of FSTL3, ADAM12, and FAT4 in Patients of Colon Cancer: Clinicopathologic Study.
Ibrahim HM; Abdelrahman AE; Elwan A; Bakry A; Fahmy MM; Abdelhamid MI; Abdelwanis AH; Fouad EM
Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):673-681. PubMed ID: 37751246
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C
Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415
[TBL] [Abstract][Full Text] [Related]
32. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A
Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492
[TBL] [Abstract][Full Text] [Related]
33. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
Ahn S; Hyeon J; Park CK
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
[TBL] [Abstract][Full Text] [Related]
34. R-Spondin1/LGR5 Activates TGFβ Signaling and Suppresses Colon Cancer Metastasis.
Zhou X; Geng L; Wang D; Yi H; Talmon G; Wang J
Cancer Res; 2017 Dec; 77(23):6589-6602. PubMed ID: 28939678
[TBL] [Abstract][Full Text] [Related]
35. Differential localization of LGR5 and Nanog in clusters of colon cancer stem cells.
Amsterdam A; Raanan C; Schreiber L; Freyhan O; Fabrikant Y; Melzer E; Givol D
Acta Histochem; 2013 May; 115(4):320-9. PubMed ID: 23098761
[TBL] [Abstract][Full Text] [Related]
36. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
[TBL] [Abstract][Full Text] [Related]
37. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.
Kang XL; He LR; Chen YL; Wang SB
World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966
[TBL] [Abstract][Full Text] [Related]
38. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer.
Valladares-Ayerbes M; Blanco-Calvo M; Reboredo M; Lorenzo-Patiño MJ; Iglesias-Díaz P; Haz M; Díaz-Prado S; Medina V; Santamarina I; Pértega S; Figueroa A; Antón-Aparicio LM
Int J Mol Sci; 2012; 13(4):4367-4387. PubMed ID: 22605983
[TBL] [Abstract][Full Text] [Related]
40. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival.
Wu XS; Xi HQ; Chen L
World J Surg Oncol; 2012 Nov; 10():244. PubMed ID: 23153436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
